We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Enterprise Therapeutics Receives Funding from Cystic Fibrosis Trust

News   Apr 05, 2017 | Original story from Enterprise Therapeutics

 
Enterprise Therapeutics Receives Funding from Cystic Fibrosis Trust
 
 
 

RELATED ARTICLES

Epigenetic Treatments Could Trigger Aggressive Tumors

News

A team headed by ICREA researchers Salvador Aznar Benitah and Fran Supek concludes that care should be taken with drugs that inhibit epigenetic factors.

READ MORE

10-20% of Cells in a Kidney Organoid Found to be Non-Renal

News

Single-cell transcriptomics revealed 10-20% of cells in a kidney organoid were non-renal cells.

READ MORE

Molecule Could Transform the Treatment of Diabetes

News

Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE